Zobrazeno 1 - 2
of 2
pro vyhledávání: '"YEARS Investigators"'
Autor:
Hendriks, S.V., Hout, W.B. van den, Bemmel, T. van, Bistervels, I.M., Eijsvogel, M., Faber, L.M., Hofstee, H.M.A., Hulle, T. van der, Sol, A.I. del, Kruip, M.J.H.A., Mairuhu, A.T.A., Middeldorp, S., Nijkeuter, M., Huisman, M.V., Klok, F.A., YEARS Investigators
Publikováno v:
Thrombosis and Haemostasis, 122(3), 427-433. Georg Thieme Verlag
None
Thrombosis and Haemostasis. GEORG THIEME VERLAG KG
Thrombosis and Haemostasis
Thrombosis and Haemostasis, 122, 3, pp. 427-433
Thrombosis and Haemostasis, 122, 427-433
Thrombosis and haemostasis. Schattauer GmbH
None
Thrombosis and Haemostasis. GEORG THIEME VERLAG KG
Thrombosis and Haemostasis
Thrombosis and Haemostasis, 122, 3, pp. 427-433
Thrombosis and Haemostasis, 122, 427-433
Thrombosis and haemostasis. Schattauer GmbH
Background Venous thromboembolism constitutes substantial health care costs amounting to approximately 60 million euros per year in the Netherlands. Compared with initial hospitalization, home treatment of pulmonary embolism (PE) is associated with a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ea3add989321dcb998c85259cc6ac3a
https://hdl.handle.net/1887/3229729
https://hdl.handle.net/1887/3229729
Autor:
Hendriks, S.V., Bavalia, R., Bemmel, T. van, Bistervels, I.M., Eijsvogel, M., Faber, L.M., Fogteloo, J., Hofstee, H.M.A., Hulle, T. van der, Sol, A.I. del, Kruip, M.J.H.A., Mairuhu, A.T.A., Middeldorp, S., Nijkeuter, M., Huisman, M.V., Klok, F.A., YEARS Investigators
Publikováno v:
Thrombosis research, 193, 60-65. Elsevier Limited
Thrombosis Research: Vascular Obstruction, Hemorrhage and Hemostasis, 193, 60-65. PERGAMON-ELSEVIER SCIENCE LTD
Thrombosis Research, 193, 60-65. Elsevier Ltd.
Thrombosis Research: Vascular Obstruction, Hemorrhage and Hemostasis, 193, 60-65. PERGAMON-ELSEVIER SCIENCE LTD
Thrombosis Research, 193, 60-65. Elsevier Ltd.
Background: Studies have shown the safety of home treatment of patients with pulmonary embolism (PE) at low risk of adverse events. Management studies focusing on home treatment have suggested that 30% to 55% of acute PE patients could be treated at
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fcea8885167cdad9012f63a0ab25f2d3
https://pure.amc.nl/en/publications/current-practice-patterns-of-outpatient-management-of-acute-pulmonary-embolism-a-posthoc-analysis-of-the-years-study(d0020678-7c3d-460a-8f0c-18cd36ccee2d).html
https://pure.amc.nl/en/publications/current-practice-patterns-of-outpatient-management-of-acute-pulmonary-embolism-a-posthoc-analysis-of-the-years-study(d0020678-7c3d-460a-8f0c-18cd36ccee2d).html